 | • レポートコード：QY2207C3464 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のグルテチミドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にグルテチミドの世界市場のxxx％を占める「錠剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のグルテチミドの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのグルテチミド市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのグルテチミド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 グルテチミドのグローバル主要メーカーには、Pfizer、Abbott Laboratories、Mankind Pharma、Glaxosimithkine、Sanofi、Novartis、Abbvie、Bristol Mayers Squibb、Astrazeneca、Agilent Technologiesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 グルテチミド市場は、種類と用途によって区分されます。世界のグルテチミド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 錠剤、注射、カプセル 【用途別セグメント】 病院薬局、小売薬局、オンライン薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - グルテチミド製品概要 - 種類別市場（錠剤、注射、カプセル） - 用途別市場（病院薬局、小売薬局、オンライン薬局） - 調査の目的 ・エグゼクティブサマリー - 世界のグルテチミド販売量予測2017-2028 - 世界のグルテチミド売上予測2017-2028 - グルテチミドの地域別販売量 - グルテチミドの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別グルテチミド販売量 - 主要メーカー別グルテチミド売上 - 主要メーカー別グルテチミド価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（錠剤、注射、カプセル） - グルテチミドの種類別販売量 - グルテチミドの種類別売上 - グルテチミドの種類別価格 ・用途別市場規模（病院薬局、小売薬局、オンライン薬局） - グルテチミドの用途別販売量 - グルテチミドの用途別売上 - グルテチミドの用途別価格 ・北米市場 - 北米のグルテチミド市場規模（種類別、用途別） - 主要国別のグルテチミド市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのグルテチミド市場規模（種類別、用途別） - 主要国別のグルテチミド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のグルテチミド市場規模（種類別、用途別） - 主要国別のグルテチミド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のグルテチミド市場規模（種類別、用途別） - 主要国別のグルテチミド市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのグルテチミド市場規模（種類別、用途別） - 主要国別のグルテチミド市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer、Abbott Laboratories、Mankind Pharma、Glaxosimithkine、Sanofi、Novartis、Abbvie、Bristol Mayers Squibb、Astrazeneca、Agilent Technologies ・産業チェーン及び販売チャネル分析 - グルテチミドの産業チェーン分析 - グルテチミドの原材料 - グルテチミドの生産プロセス - グルテチミドの販売及びマーケティング - グルテチミドの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - グルテチミドの産業動向 - グルテチミドのマーケットドライバー - グルテチミドの課題 - グルテチミドの阻害要因 ・主な調査結果 |
Glutethimide is a hypnotic sedative drug which is a safe alternative to barbiturates for treatment of insomnia. It mainly used for patients to feel sleepy and make them calm. Glutethimide is highly lipophilic and concentrates in adipose tissue and brain. It is an alternative for barbiturates. It undergoes extensive metabolism in liver with both unconjugated and conjugated metabolites which kidney excretes. Glutethimide is a CYP2D6 enzyme inducer and when it taken with codeine, it enables the body to convert high amount of codeine to morphine. The most common brand name for glutethimide are ciba, glue, and gofers. It is categorized as schedule II drug under psychotropic substances. Moreover, glutethimide is used to prevent jaundice in newborns and reduce muscle tremors.
Market Analysis and Insights: Global Glutethimide Market
The global Glutethimide market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Tablets accounting for % of the Glutethimide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Glutethimide market size is valued at US$ million in 2021, while the North America and Europe Glutethimide are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Glutethimide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glutethimide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glutethimide market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glutethimide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glutethimide market.
Global Glutethimide Scope and Market Size
Glutethimide market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Glutethimide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tablets
Injection
Capsules
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Company
Pfizer
Abbott Laboratories
Mankind Pharma
Glaxosimithkine
Sanofi
Novartis
Abbvie
Bristol Mayers Squibb
Astrazeneca
Agilent Technologies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glutethimide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Injection
1.2.4 Capsules
1.3 Market by Application
1.3.1 Global Glutethimide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Glutethimide Market Perspective (2017-2028)
2.2 Glutethimide Growth Trends by Region
2.2.1 Glutethimide Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Glutethimide Historic Market Size by Region (2017-2022)
2.2.3 Glutethimide Forecasted Market Size by Region (2023-2028)
2.3 Glutethimide Market Dynamics
2.3.1 Glutethimide Industry Trends
2.3.2 Glutethimide Market Drivers
2.3.3 Glutethimide Market Challenges
2.3.4 Glutethimide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Glutethimide Players by Revenue
3.1.1 Global Top Glutethimide Players by Revenue (2017-2022)
3.1.2 Global Glutethimide Revenue Market Share by Players (2017-2022)
3.2 Global Glutethimide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Glutethimide Revenue
3.4 Global Glutethimide Market Concentration Ratio
3.4.1 Global Glutethimide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glutethimide Revenue in 2021
3.5 Glutethimide Key Players Head office and Area Served
3.6 Key Players Glutethimide Product Solution and Service
3.7 Date of Enter into Glutethimide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Glutethimide Breakdown Data by Type
4.1 Global Glutethimide Historic Market Size by Type (2017-2022)
4.2 Global Glutethimide Forecasted Market Size by Type (2023-2028)
5 Glutethimide Breakdown Data by Application
5.1 Global Glutethimide Historic Market Size by Application (2017-2022)
5.2 Global Glutethimide Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Glutethimide Market Size (2017-2028)
6.2 North America Glutethimide Market Size by Type
6.2.1 North America Glutethimide Market Size by Type (2017-2022)
6.2.2 North America Glutethimide Market Size by Type (2023-2028)
6.2.3 North America Glutethimide Market Share by Type (2017-2028)
6.3 North America Glutethimide Market Size by Application
6.3.1 North America Glutethimide Market Size by Application (2017-2022)
6.3.2 North America Glutethimide Market Size by Application (2023-2028)
6.3.3 North America Glutethimide Market Share by Application (2017-2028)
6.4 North America Glutethimide Market Size by Country
6.4.1 North America Glutethimide Market Size by Country (2017-2022)
6.4.2 North America Glutethimide Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Glutethimide Market Size (2017-2028)
7.2 Europe Glutethimide Market Size by Type
7.2.1 Europe Glutethimide Market Size by Type (2017-2022)
7.2.2 Europe Glutethimide Market Size by Type (2023-2028)
7.2.3 Europe Glutethimide Market Share by Type (2017-2028)
7.3 Europe Glutethimide Market Size by Application
7.3.1 Europe Glutethimide Market Size by Application (2017-2022)
7.3.2 Europe Glutethimide Market Size by Application (2023-2028)
7.3.3 Europe Glutethimide Market Share by Application (2017-2028)
7.4 Europe Glutethimide Market Size by Country
7.4.1 Europe Glutethimide Market Size by Country (2017-2022)
7.4.2 Europe Glutethimide Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Glutethimide Market Size (2017-2028)
8.2 Asia-Pacific Glutethimide Market Size by Type
8.2.1 Asia-Pacific Glutethimide Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Glutethimide Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Glutethimide Market Share by Type (2017-2028)
8.3 Asia-Pacific Glutethimide Market Size by Application
8.3.1 Asia-Pacific Glutethimide Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Glutethimide Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Glutethimide Market Share by Application (2017-2028)
8.4 Asia-Pacific Glutethimide Market Size by Region
8.4.1 Asia-Pacific Glutethimide Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Glutethimide Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Glutethimide Market Size (2017-2028)
9.2 Latin America Glutethimide Market Size by Type
9.2.1 Latin America Glutethimide Market Size by Type (2017-2022)
9.2.2 Latin America Glutethimide Market Size by Type (2023-2028)
9.2.3 Latin America Glutethimide Market Share by Type (2017-2028)
9.3 Latin America Glutethimide Market Size by Application
9.3.1 Latin America Glutethimide Market Size by Application (2017-2022)
9.3.2 Latin America Glutethimide Market Size by Application (2023-2028)
9.3.3 Latin America Glutethimide Market Share by Application (2017-2028)
9.4 Latin America Glutethimide Market Size by Country
9.4.1 Latin America Glutethimide Market Size by Country (2017-2022)
9.4.2 Latin America Glutethimide Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Glutethimide Market Size (2017-2028)
10.2 Middle East & Africa Glutethimide Market Size by Type
10.2.1 Middle East & Africa Glutethimide Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Glutethimide Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Glutethimide Market Share by Type (2017-2028)
10.3 Middle East & Africa Glutethimide Market Size by Application
10.3.1 Middle East & Africa Glutethimide Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Glutethimide Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Glutethimide Market Share by Application (2017-2028)
10.4 Middle East & Africa Glutethimide Market Size by Country
10.4.1 Middle East & Africa Glutethimide Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Glutethimide Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Glutethimide Introduction
11.1.4 Pfizer Revenue in Glutethimide Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Glutethimide Introduction
11.2.4 Abbott Laboratories Revenue in Glutethimide Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 Mankind Pharma
11.3.1 Mankind Pharma Company Details
11.3.2 Mankind Pharma Business Overview
11.3.3 Mankind Pharma Glutethimide Introduction
11.3.4 Mankind Pharma Revenue in Glutethimide Business (2017-2022)
11.3.5 Mankind Pharma Recent Developments
11.4 Glaxosimithkine
11.4.1 Glaxosimithkine Company Details
11.4.2 Glaxosimithkine Business Overview
11.4.3 Glaxosimithkine Glutethimide Introduction
11.4.4 Glaxosimithkine Revenue in Glutethimide Business (2017-2022)
11.4.5 Glaxosimithkine Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Glutethimide Introduction
11.5.4 Sanofi Revenue in Glutethimide Business (2017-2022)
11.5.5 Sanofi Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Glutethimide Introduction
11.6.4 Novartis Revenue in Glutethimide Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Glutethimide Introduction
11.7.4 Abbvie Revenue in Glutethimide Business (2017-2022)
11.7.5 Abbvie Recent Developments
11.8 Bristol Mayers Squibb
11.8.1 Bristol Mayers Squibb Company Details
11.8.2 Bristol Mayers Squibb Business Overview
11.8.3 Bristol Mayers Squibb Glutethimide Introduction
11.8.4 Bristol Mayers Squibb Revenue in Glutethimide Business (2017-2022)
11.8.5 Bristol Mayers Squibb Recent Developments
11.9 Astrazeneca
11.9.1 Astrazeneca Company Details
11.9.2 Astrazeneca Business Overview
11.9.3 Astrazeneca Glutethimide Introduction
11.9.4 Astrazeneca Revenue in Glutethimide Business (2017-2022)
11.9.5 Astrazeneca Recent Developments
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Details
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Glutethimide Introduction
11.10.4 Agilent Technologies Revenue in Glutethimide Business (2017-2022)
11.10.5 Agilent Technologies Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer